Skip to content
City PM
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Opinion
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Opinion
Friday 08 December 2023 11:14 am

Investors express concern about Mike Lynch’s influence at Darktrace

By: Jess Jones

TMT Reporter

Add as a preferred source on Google
Former Autonomy boss Mike Lynch settles data claim with SFO days before trial

Investors in cybersecurity firm Darktrace have expressed their disapproval of the company’s affiliation with scandal-stricken British entrepreneur Mike Lynch by rejecting the appointment of his representative to the company’s board.

At the company’s annual meeting, 56.67 per cent of shareholders voted against the election of Patrick Jacob as a non-executive director, representing the interests of Lynch, who is currently embroiled in a US fraud trial.

One institutional investor wrote to the company: “Mike Lynch’s trial in the US creates unhelpful headline risk for Darktrace which we view as unwarranted, so any move to distance Darktrace from these headlines is a positive in our eyes.

“Additionally, we do not believe granting a board seat to Invoke is conducive to helping Darktrace develop and mature as a global business and investment.”

Lynch faces charges related to the $11bn (£8.7bn) sale of Autonomy to Hewlett-Packard. He has denied any wrongdoing.

Invoke Capital, Lynch’s investment vehicle that seeded Darktrace, brought former Autonomy staff, including chief executive Poppy Gustafsson and chief of technology Jack Stockdale, into Darktrace’s fold.

Gustafsson has been trying to distance herself from Lynch of late. She recently refused to go to the US to give testimony in Lynch’s criminal trial.

Seeking to sever perceived links between the alleged fraud and Darktrace, the company appointed two independent non-executive directors this month.

The London-listed company’s shares are up over 14 per cent over the past year.

City PM has reached out to Darktrace for comment.

Track all markets on TradingView
Read more

Mike Ashley’s Frasers makes £166m play for shoe firm Accent

Mike Ashley has been working with Hornby since March.

Share this article

  • Facebook
  • X
  • LinkedIn
  • WhatsApp
  • Email

Similarly tagged content:

Sections

  • News

Categories

  • Tech

Related Topics

  • Company

Trending Articles

  • Top Burnham adviser calls for capital gains and inheritance tax hikes

  • Clarkson’s Farm and why businesses must stop blaming the weather

  • Two solicitors linked to Post Office scandal charged with misconduct

  • Lloyd’s deputy chair: The City is a club in the best sense

  • Revealed: Secret Treasury plan to tax State Pension before it is paid out

More from City PM

  • Mike Ashley’s Frasers makes £166m play for shoe firm Accent

    Retail
    Mike Ashley has been working with Hornby since March.
  • Hugo Boss shares soar as Mike Ashley’s Frasers circles

    Retail
    Mike Ashley, founder of Frasers Group Plc. Photographer: Chris J. Ratcliffe/Bloomberg via Getty Images
  • Mike Ashley’s Frasers makes £1.7bn takeover offer for Hugo Boss

    Business
    Unfortunately, Im unable to provide the alt text as there is no information given about the content or context of the arti...
  • From bathroom to courtroom: Lush chief’s squabble set to fizz in £6m trial

    Legal
    GettyImages 2245687120 showcasing a business professional in a modern office setting, conveying a sense of productivity an...
  • Optimum Asset Management’s Investor Summit in Portofino brings together Mike Pompeo, Matteo Renzi and leaders across government, finance and industry to discuss the future of the global economy and geopolitics

    Business Wire
  • AngloGold Ashanti Announces Date for General Meeting of Shareholders in Relation to Proposed Share Repurchase Programme

    Business Wire
  • As it happened: Starmer dealt defence blow as investors react

    Markets
    Healey and Starmer engage in discussion at a public event, focusing on key policy issues and future strategies.
  • Silence Therapeutics Highlights Follow-Up Data at EHA 2026 Demonstrating Durable Efficacy and Potential Best-in-Class Profile for Divesiran in Polycythemia Vera

    Business Wire

City PM — European politics, business and analysis.

Europe

  • Germany
  • France
  • Europe
  • UK & Ireland

Topics

  • Business
  • Markets
  • AI
  • Technology
  • Opinion
  • Energy

More

  • Politics
  • Economics
  • Fintech
  • Legal
  • Sport
  • Life

Company

  • About City PM
  • Editorial Policy
  • Corrections
  • Contact
  • Terms of Use
  • Privacy Policy
  • Cookie Policy
© 2026 City PM · Published by CityPM Media, Bahnhofstrasse 65, 8001 Zürich, Switzerland
About · Editorial Policy · Corrections · Contact · Privacy